These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25734941)

  • 1. Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.
    Lupón J; Gaggin HK; de Antonio M; Domingo M; Galán A; Zamora E; Vila J; Peñafiel J; Urrutia A; Ferrer E; Vallejo N; Januzzi JL; Bayes-Genis A
    Int J Cardiol; 2015 Apr; 184():337-343. PubMed ID: 25734941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study.
    Lupón J; Sanders-van Wijk S; Januzzi JL; de Antonio M; Gaggin HK; Pfisterer M; Galán A; Shah R; Brunner-La Rocca HP; Bayes-Genis A
    Int J Cardiol; 2016 Feb; 204():242-7. PubMed ID: 26682955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Lelonek M
    Kardiol Pol; 2014; 72(8):725-34. PubMed ID: 24846354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST2 pathogenetic profile in ambulatory heart failure patients.
    Bayes-Genis A; Januzzi JL; Gaggin HK; de Antonio M; Motiwala SR; Zamora E; Galán A; Domingo M; Urrutia A; Lupón J
    J Card Fail; 2015 Apr; 21(4):355-61. PubMed ID: 25451702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
    Ahmad T; Fiuzat M; Neely B; Neely ML; Pencina MJ; Kraus WE; Zannad F; Whellan DJ; Donahue MP; Piña IL; Adams KF; Kitzman DW; O'Connor CM; Felker GM
    JACC Heart Fail; 2014 Jun; 2(3):260-8. PubMed ID: 24952693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
    Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
    J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF.
    Daubert MA; Adams K; Yow E; Barnhart HX; Douglas PS; Rimmer S; Norris C; Cooper L; Leifer E; Desvigne-Nickens P; Anstrom K; Fiuzat M; Ezekowitz J; Mark DB; O'Connor CM; Januzzi J; Felker GM
    JACC Heart Fail; 2019 Feb; 7(2):158-168. PubMed ID: 30611722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Di Tano G; Caretta G; De Maria R; Parolini M; Bassi L; Testa S; Pirelli S
    Heart; 2017 Jan; 103(1):71-77. PubMed ID: 27465055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy.
    Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31731547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure.
    Arzilli C; Aimo A; Vergaro G; Ripoli A; Senni M; Emdin M; Passino C
    Eur J Prev Cardiol; 2018 May; 25(8):889-895. PubMed ID: 29569494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
    Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M
    Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.
    Truong QA; Januzzi JL; Szymonifka J; Thai WE; Wai B; Lavender Z; Sharma U; Sandoval RM; Grunau ZS; Basnet S; Babatunde A; Ajijola OA; Min JK; Singh JP
    Heart Rhythm; 2014 Dec; 11(12):2167-75. PubMed ID: 25014756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction.
    Weir RA; Miller AM; Murphy GE; Clements S; Steedman T; Connell JM; McInnes IB; Dargie HJ; McMurray JJ
    J Am Coll Cardiol; 2010 Jan; 55(3):243-50. PubMed ID: 20117403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-flow severe aortic stenosis with preserved ejection fraction, N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiovascular remodeling.
    Mizia-Stec K; Adamczyk T; Mizia M; Haberka M; Gasior Z; Trusz-Gluza M; Tendera M
    J Heart Valve Dis; 2011 May; 20(3):301-10. PubMed ID: 21714421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.